MedPath

Evaluation of the effect of rosuvastatin on renoprotective effect

Not Applicable
Recruiting
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000021583
Lead Sponsor
Rosuvastatin-kidney study group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patient is started or changed renin angiotensin system inhibitor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of urinary nephrin excretion after 6 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath